EP0374248B1 - Messgerät zur messung des herzflusses - Google Patents

Messgerät zur messung des herzflusses Download PDF

Info

Publication number
EP0374248B1
EP0374248B1 EP88902239A EP88902239A EP0374248B1 EP 0374248 B1 EP0374248 B1 EP 0374248B1 EP 88902239 A EP88902239 A EP 88902239A EP 88902239 A EP88902239 A EP 88902239A EP 0374248 B1 EP0374248 B1 EP 0374248B1
Authority
EP
European Patent Office
Prior art keywords
cardiac output
data
blood
temperature
indicator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP88902239A
Other languages
English (en)
French (fr)
Other versions
EP0374248A1 (de
EP0374248A4 (en
Inventor
Shigekazu Terumo Kabushiki Kaisha Sekii
Makoto Terumo Kabushiki Kaisha Ikeda
Kouji Terumo Kabushiki Kaisha Tsuchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP62048826A external-priority patent/JPS63216539A/ja
Priority claimed from JP62048824A external-priority patent/JPS63216537A/ja
Priority claimed from JP62048823A external-priority patent/JPS63216536A/ja
Priority claimed from JP62048825A external-priority patent/JPS63216538A/ja
Priority claimed from JP62048821A external-priority patent/JPS63216540A/ja
Priority to EP93119023A priority Critical patent/EP0599314B1/de
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to EP93119022A priority patent/EP0596539B1/de
Publication of EP0374248A1 publication Critical patent/EP0374248A1/de
Publication of EP0374248A4 publication Critical patent/EP0374248A4/en
Publication of EP0374248B1 publication Critical patent/EP0374248B1/de
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/0275—Measuring blood flow using tracers, e.g. dye dilution
    • A61B5/028—Measuring blood flow using tracers, e.g. dye dilution by thermo-dilution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/0275—Measuring blood flow using tracers, e.g. dye dilution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/029—Measuring or recording blood output from the heart, e.g. minute volume

Definitions

  • the present invention relates to a cardiac output measuring apparatus for use in a cardiac function inspection or the like.
  • the measurement of cardiac output by right heart catheterization which is performed in a cardiac function inspection, employs the indicator dilution method.
  • This indicator dilution method is classified into three categories: the thermal dilution method in which the cardiac output is obtained by utilizing thermal diffusion, the dye dilution method in which the cardiac output is obtained utilizing variations in the illuminance which are caused by the diffusion of a dye, and the electrolyte dilution method in which the cardiac output is obtained utilizing variations in the resistance caused by the diffusion of an electrolyte.
  • the thermal dilution method will be described below in detail.
  • a catheter 25 is introduced into the body from the cervical vein, the femoral vein, the basilic vein or the like.
  • the forward end of the catheter passes through the superior vena cava or the inferior vena cava, the right atrium and then the right ventricle, and finally reaches the pulmonary artery, as shown in Fig. 16.
  • the catheter 25 has a injection port 26 and a thermistor 27, which are respectively positioned in the right atrium and in the pulmonary artery when the forward end of the catheter 25 is located within the pulmonary artery.
  • CO is the cardiac output
  • Si is the specific gravity of the injectate
  • Ci is the specific heat of the injectate
  • Vi is the volume of injectate
  • Ti is the temperature of the injectate
  • Tb is the temperature of the blood
  • Sb is the specific gravity of the blood
  • Cb is the specific heat of the blood
  • ⁇ 0 ⁇ ⁇ Tb dt is the area of the thermal dilution curve.
  • an object of the present invention is to provide a cardiac output measuring apparatus which is capable of continuously measuring and recording a cardiac output over a long period of time, and which enables a correction term relating to the volume of an indicator remaining in a catheter that can be the cause of the measurement errors to be numerically input as a value realistic to an operator so as to ensure simple and easy operation of the apparatus.
  • the present invention provides an apparatus, as specified in claim 1.
  • the blood data detection means includes a temperature sensor, and the blood data represents data on the temperature of the blood.
  • the injection means includes a catheter, and the data on the heat capacity represents the volume of indicator injected, the outer diameter of the catheter, or the temperature of the indicator.
  • the dilution method is a thermal dilution method.
  • the blood data detection means includes a catheter having an opening through which the indicator is injected into the blood, a first thermistor for measuring the temperature of the blood diluted by the indicator at the downstream side of the blood vessel, an integrating means for integrating the blood temperature data detected by the thermistor, and a second, self-heating type thermistor provided in the vicinity of the first thermistor of the catheter.
  • the cardiac output measuring apparatus includes a first microprocessor for collecting data, a second microprocessor for processing data, and a communication means for exchanging data between the two microprocessors.
  • the first microprocessor collects the blood temperature data detected by the first thermistor and the heat balanced temperature data detected by the second thermistor, and sends them to the second microprocessor by means of the communication means.
  • the second microprocessor processes the data collected and thereby operates the initial cardiac output and the function. In consequence, the data collection and the data processing are performed in parallel by the corresponding microprocessors, and this allows accurate cardiac output data to be offered to the operator at a high speed.
  • the cardiac output operation means includes a means for compressing the cardiac outputs operated within a predetermined period of time, and a memory for storing the cardiac outputs compressed.
  • the recording means is capable of recording the cardiac outputs compressed. In consequence, continuous measurement and data recording can be performed over a long period of time.
  • the cardiac output measuring means comprises a data setting means for manually setting data on an indicator which is not yet injected into the blood vessel, indicator measuring means for measuring data on the indicator which is not yet injected into the blood vessel, said blood data detection means detecting data on the blood which is diluted by the indicator injected into the blood vessel, and said integration means integrating the blood data obtained at each time, and selection means for selecting either the data set by said data setting means or the data obtained by said indicator measuring means, wherein said cardiac output operation means operates a cardiac output from the integral value obtained by the integration means and the selected value by the selection means.
  • the data manually preset by means of the data setting means can be employed in place of that data, thereby making the operation of the apparatus simple.
  • the indicator measuring means includes a measuring probe connected to the cardiac output measuring apparatus, and the cardiac output measuring apparatus further includes a non-connection detection means for detecting non-connection of the measuring probe to said cardiac output measuring apparatus. Only when the non-connection detection means detects non-connection, the selection means selects the data input from the input means as the indicator data. In this way, the measuring apparatus determines that the operator considers it unnecessary to perform measurement of data required for calculation.
  • the indicator data represents the temperature of the indicator.
  • the data setting means includes numeric input keys.
  • Figs. 1A, 1B and 1C are respectively plan, front and rear views of a cardiac output continuous measuring/recording apparatus to which the present invention is applied.
  • Fig. 2A shows the external view of a catheter connected to the measuring apparatus of Fig. 1
  • Fig. 2B is a cross-section of the forward end portion of the catheter which is taken in the longitudinal direction thereof
  • Fig. 2C is a cross-section of the catheter, showing openings formed in the catheter.
  • the measuring apparatus operates on the basis of the following principles.
  • an initial cardiac output COo is measured by the indicator dilution method, such as the thermal dilution method, the electrolyte dilution method or the dye dilution method, and then the blood flow velocity Vo at the time when the cardiac output is measured is measured.
  • Any type of indicator dilution method can be employed to obtain the initial cardiac output.
  • the embodiment of the present invention which will be described below, employs the thermal dilution method.
  • a reference numeral 50 denotes a recording device, such as a plotter, which outputs the results of the measurement.
  • Reference numerals 52 and 53 denote switches which are used to designate the form in which the initial cardiac output COo measured by the thermal dilution method is output to the plotter 50.
  • the switch 53 marked “Thermal Dilution Curve” is used to designate the graphical output of variations in the blood temperature Tb with a curve (Fig. 4).
  • Switches 57 and 58 are used to designate the paper feed speed (which may be 20 mm/hour and 10 mm/min) of the plotter 50.
  • a switch 54 marked “Record” is pressed to output the changes in the cardiac output COx or the like over 12 hours on the plotter 50 (as shown in Fig. 8).
  • a switch 55 marked “Reproduction” is used to output the data which is stored in a memory over 30 minutes, such as the continuously obtained cardiac output COx or the like, on the plotter 50 (as shown in Figs. 6 and 7).
  • a switch 80 marked "Memo" is a memo switch. By pressing this switch 80, a sheet of recording paper is fed by 6 cm.
  • a switch 56 marked “Continuous Recording” is used to output variations in COi, Tb, Vx or the like on real-time on the recording paper (as shown in Figs. 6 and 7).
  • the measuring apparatus 100 also measures data such as the cardiac output or the like on real-time and stores the obtained data in the memory. In consequence, the data recorded on the recording paper gradually comes close to and finally coincides with that which is being stored presently. In that case, "reproduction” mode is not stopped but the operation mode is automatically switched over to the above-described "continuous recording”.
  • Switches 59, 60 (Fig. 1A) 61 and 62 (Fig. 1B) are respectively used to manually set the diameter of a catheter (unit: Fr), the volume of injectate (unit: ml), the body surface area of an examinee (unit: m2) and the initial CAL value (unit: L/min) in the apparatus 100.
  • the initial CAL value will be described later in detail.
  • a switch 64 which is indicated as "CONTINUOUS", is used to switch over the operation mode of the apparatus 100 to the continuous mode. The switch 64 lights up when the operation mode is switched over to the continuous mode.
  • a switch 65 indicated as “SINGLE” is a switch/indicator of the single mode, which is pressed when the operation mode is to be switched over from the continuous mode to the single mode to reset the parameter S. The switch 65 lights up when the operation mode is switched over to the single mode.
  • a display 68 is a 4-digit LED which digitally displays the cardiac output. Switches 66 and 67, which are respectively indicated as “BLOOD” and “INJECTATE”, are used to designate the type of temperature displayed by a 3-digit LED 69 from among the blood temperature Tb and the injectate temperature Ti.
  • a switch/indicator 70 which is indicated as "ENTRY", displays that the measuring apparatus 100 has completed the measurement of the initial cardiac output COo by the thermal dilution method and that it is ready to register (enter) the obtained initial cardiac output COo.
  • the initial cardiac output COo is registered by pressing the switch 70 while it is lighting up. Registration of COo is performed for the purpose of obtaining the parameter S.
  • a plurality of initial cardiac outputs COo may be registered in order to increase the accuracy with which the initial cardiac output COo is obtained. More specifically, measurement of the initial cardiac output COo by the thermal dilution method is performed a plurality of times, and the operator selects the reliable data among the obtained data and registers them.
  • the initial value COo is an average value of the registered data.
  • Lighting up of a switch/indicator 72 marked “START” indicates that preparation of measurement of the initial cardiac output COo by the thermal dilution method is completed. Integration on the basis of the Stewart/Hamilton Equation starts when the switch 72 is pressed while it is lighting up.
  • a display 71 which is in the form of a bar graph, displays the blood temperature Tb on real-time.
  • Connectors 73 and 74 are respectively connected to a connector 15 of the catheter (Fig. 2A) with the blood temperature sensor incorporated therein and to a connector 16 of a temperature probe 12 (Fig. 2A) for measuring the temperature of an indicator.
  • Reference numerals 63 and 78 respectively denote a power switch and an indicator lamp which indicates the use of a battery incorporated in the apparatus.
  • a switch 75 shown in Fig. 1C is used to manually set the temperature of an indicator.
  • a reference numeral 76 denotes a connector of an RS232C interface through which the apparatus performs communications with another measuring apparatuses
  • reference numerals 78 designate terminals for outputting analog signals representing the blood temperature Tb, the blood flow velocity Vx, the cardiac output COx to another measuring apparatuses
  • a reference numeral 77 denotes a connector for connecting a power cable.
  • the measuring apparatus 100 shown in Figs. 1A to 1C and 2A to 2C is characterized in that:
  • Fig. 2A shows a catheter which incorporates a thermistor for measuring the blood temperature Tb in accordance with the thermal dilution method and a thermistor for measuring the blood flow velocity V.
  • a catheter 4 is constructed so that it has four lumens.
  • the catheter 4 has a pressure detection port 18 formed at the forward end thereof.
  • a balloon 17 with a flexible elastic body is mounted on the catheter tube at a position a few millimeters away from the forward end thereof in such a manner that it encloses the entire forward end of the catheter tube.
  • the catheter has a hole 25 formed in the portion of the catheter tube which is covered by the balloon.
  • Air (preferably, carbon dioxide) is injected into or drawn from the balloon 17 through this hole 25 so as to inflate or deflate the balloon 17.
  • a thermistor 1 is provided on the catheter tube at a position which is 10 to 20 mm away from the forward end, and a thermistor 2 is disposed at a position which is 10 to 15 mm closer to the proximal end of the catheter from the position of the thermistor 1.
  • the catheter 4 also has a injection port 3 at a position which is separated from the thermistors 1 and 2 by 8.5 to 38 cm and which is separated from the forward end by 12 to 40 cm.
  • the thermistor 1 is used to measure the heat balanced temperature which is required to measure the blood flow velocity Vo (or Vx), and the thermistor 2 is employed to measure the temperature Tb of the blood diluted, which is required to measure the initial cardiac output COo by the thermal dilution method.
  • the injection port 3 is a port through which the indicator is discharged into the blood.
  • the catheter 4 shown in Fig. 2A is introduced from the cervical vein, the femoral vein or the basilic vein. At that time, the forward end of the catheter 4 passes through the superior vena cava or the inferior vena cava, the right atrium and then the right ventricle, to rest in the pulmonary artery. In view of the blood flowing from the proximal end of the catheter toward the forward end thereof, the thermistor 2 is located on the side of the injection port 3 which is closer to the forward end (which is downstream of the injection port 3).
  • the blood flows in the reverse direction relative to the catheter, and the thermistor 2 is therefore disposed on the side of the injection port 3 which is closer to the proximal end of the catheter.
  • Fig. 2B is a cross-section of the essential parts of the catheter 4.
  • the pressure detection port 18, the balloon side hole 25 (which is shown in Fig. 2A), the thermistors 1 and 2, and the injection port 3 respectively communicate with the four lumens, which are a pulmonary arterial pressure lumen 19, a balloon lumen 20 which serves as a passageway for the air with which the balloon 17 is inflated or deflated, a thermistor lumen 21 for accommodating the thermistors 1 and 2 and the leads thereof, and an injection lumen 23 through which the dilution indicator passes.
  • a pulmonary arterial pressure measuring tube 8 a balloon tube 6, a thermistor tube 13 and an indicator injection tube 10, as shown in Fig. 2A.
  • the rear ends of the tubes 8, 6 and 10 are respectively provided with connectors 7, 8 and 11.
  • the thermistor tube 13, through which leads 22 and 24 of the thermistors 1 and 2 pass, is connected to the connector, which is in turn connected to the connector 73 of the measuring apparatus 100.
  • Fig. 2B is an enlarged cross-section of the portion of the catheter on which the thermistors 1 and 2 and the balloon 17 are mounted
  • Fig. 2C is a section taken along the line III - III' of Fig. 2B.
  • the catheter 4 has four lumens which are the balloon lumen 20, the pulmonary arterial pressure lumen 19, the injection lumen 23 (Fig. 2C), and the thermistor lumen 21.
  • the balloon lumen 20, which has the balloon side hole 25, communicates with the balloon tube 6.
  • the pulmonary arterial pressure lumen 19 with the pressure detection port 18 communicates with the pulmonary arterial pressure measuring tube 8.
  • the injection lumen 23 has the injection port 3 at a position which is separated from the forward end of the catheter by 12 to 40 cm.
  • the injection lumen 23 communicates with the indicator injection tube 10 provided at the proximal end of the catheter.
  • the thermistor lumen 21 has side holes 26 and 27 on which the thermistors 1 and 2 are mounted at a position which is separated from the forward end of the catheter by 1 to 2 cm and at a position which is separated from the position of the side hole 26 by 1 to 1.5 cm toward the proximal end of the catheter, respectively.
  • the leads 22 and 24 for the thermistors 1 and 2 are passed through the lumen 21.
  • the proximal end of the lumen 21 communicates with the thermistor tube 13.
  • the thermistor 1, which may be of the self-heating type, is located downstream of the thermistor 2. More specifically, when the cardiac output is to be measured by means of the catheter 4, it is necessary that the temperature of the diluted blood be measured by the thermistor 2 with a high degree of accuracy. If the thermistor 1 is located downstream of the thermistor 2, the thermistor 2 will be less affected by the self-heating type thermistor 1. Despite of this, the thermistor 1 may be provided in a different position from that shown in Fig. 2A, i.e., it may be located upstream of the thermistor 2 by 10 to 15 mm so that it can be correctly located within the pulmonary artery.
  • the injectate temperature measuring probe 12 shown in Fig. 2A has a thermistor 12a in the vicinity of the forward end thereof.
  • the rear end of the probe 12 is connected to a connector 16, which is in turn connected to the connector 74 of the measuring apparatus 100.
  • step S1 the injectate temperature probe 12 is connected to the measuring apparatus 100.
  • step S2 the probe 12 is immersed in the indicator contained in an ice-cooled container (which is provided within the measuring apparatus 100).
  • the indicator may be a physiological salt solution or the like.
  • the catheter 4 is primed in step S3, and it is then inserted into the pulmonary artery in step S4.
  • the catheter 4 is introduced from the vein or the like of the superior limb or the inferior limb, and is finally led into the pulmonary artery.
  • step S5 the connectors of the catheter shown in Fig. 2A are connected to the measuring apparatus body 100.
  • the position of the catheter 4 which is moving within the blood vessel is detected on the basis of the blood pressure, such as the central venous pressure, the right atrium pressure, the right ventricle pressure or the pulmonary arterial pressure, as well as the pressure waveforms, the blood pressure being detected through the pressure detection port 18, the tube 8 and the connector 9.
  • the pulmonary arterial pressure is measured, and then the pulmonary artery wedge pressure is obtained by closing the pulmonary artery by means of the inflated balloon 17.
  • step 56 certain values are set in the switches 59, 60 and 61.
  • the switch 62 is used when a relative COx is to be measured (which will be described later).
  • the switch 62 is not thus used when the initial cardiac output COo is to be measured by the thermal dilution method.
  • step S7 the measuring apparatus is turned on.
  • step S8 it is determined whether or not there is an abnormal display (which indicates the failure of the apparatus), and then the lighting up of the SINGLE indicator 65 is awaited in step S9. Once the indicator 65 lights up, the BLOOD indicator 66 lights up, which indicates that the temperature displayed on the display 69 is the blood temperature Tb. If it is desired to display the injectate temperature at that time, the display of the display is switched over to that of the injectate temperature Ti by pressing the INJECTATE switch 67. At that time, the bar graph display 71 is displaying the base line of the blood temperature Tb.
  • the display of Ti is automatically switched over to that of the blood temperature Tb after 30 seconds have elapsed, and Tb is thereby displayed again on the display 69. This arrangement is made because the display of Tb is more significant to the operator than that of Ti.
  • step S10 the lighting up of the START indicator 72 is awaited.
  • the lighting up of the START indicator 72 means that preparation for measurement of the initial cardiac output COo by the thermal dilution method has been made.
  • step S11 either the switch 52 or the switch 53 is pressed, if necessary, to select the form in which the data is output to the plotter 50.
  • step S12 a cock 11 is opened to inject the indicator into the blood vessel.
  • the measuring apparatus 100 After the injection, the measuring apparatus 100 automatically reads the changes in Tb and determines the optimal point at which integration is started. If the operator presses the START switch 72 before the optimal point is detected, integration of Tb is started at that point. If the switch 72 is not pressed, the apparatus determines the optimal point at which integration of Tb is started by itself. It generally takes somewhat more than 10 seconds for the calculation of the cardiac output by the thermal dilution method to be completed. The changes in Tb which occur during the calculation are stored in a predetermined memory (which is a RAM 132 shown in Fig. 9). At the same time, they are displayed by the display 69 and the bar graph display 71. Furthermore, changes in the blood temperature Tb are output to the plotter 50, as shown in Fig.
  • a predetermined memory which is a RAM 132 shown in Fig. 9
  • the switch 53 has been pressed beforehand.
  • the operator can confirm the normal operation of the apparatus with these displays.
  • the axis of the ordinate rises as the blood temperature Tb falls.
  • the date, the time and so on of the measurement may also be output on the graph for the convenience of the examiner.
  • the graph shown in Fig. 4 may be output at a speed of 300 mm/min.
  • the obtained value is digitally displayed by the display 68.
  • the results of the measurement shown in Fig. 5 are output by the plotter 50, if the switch 52 has been pressed.
  • Completion of the measurement of the initial cardiac output COo can be confirmed by the lighting up (in step S15) of the ENTRY indicator 70.
  • step S17 If the operator judges that the data thus-obtained is reliable, he or she presses the ENTRY switch 70 (in step S17) to register the data. After a while, the START indicator 72 lights up again, and the measurement of the initial cardiac output COo by the thermal dilution method is thereby completed.
  • a plurality of data are registered by pressing the ENTRY switch 70 each time data is obtained by repeating the processings from step S11 to step S17. An average value of the plurality of COo values is then obtained to determine the initial cardiac output COo.
  • Fig. 6 shows an example of the graph which is output at a paper feeding speed of 10 mm/min
  • Fig. 7 shows an example of the graph which is output at a speed of 20 mm/hour.
  • various types of data such as those shown in Fig. 5, may also be output together with the graph.
  • the measurement of the initial cardiac output COo was performed the second time at about 16 : 30.
  • a vertical line is used to indicate the fact that measurement of the initial cardiac output COo is performed in the measuring apparatus 100.
  • Fig. 9 is a circuit diagram of the measuring apparatus 100 with the catheter 4 and the injectate temperature probe 12 being connected thereto.
  • the measuring apparatus 100 includes two measuring circuits 120 (Fig. 9A) and 130 (Fig. 9B), which are electrically isolated from each other.
  • the measuring circuit 120 has the function of converting the electrical signals from the thermistors 1 and 2 incorporated in the catheter 4 and the thermistor 12a in the probe 12 into temperature data and of sending it to the measuring/recording circuit 130 through an optical communication circuit 108.
  • the measuring/recording circuit 130 has the function of operating from the temperature data from the measuring circuit 120 the initial cardiac output COo, the blood flow velocity Vo (or Vx), the parameter S the continuous cardiac output COx and so on and of displaying the data on the plotter 50 or other various types of displays.
  • the measuring circuit 120 is controlled by a local CPU 105, and the measuring/recording circuit 130 is controlled by a main CPU 133.
  • a catheter type sensor 150 shown in Fig. 9 employs the catheter shown in Fig. 2A.
  • the sensor 150 incorporates the self-heating type thermistor 1 for detecting a heat-balanced temperature, and the thermistor 2 for detecting the temperature of the blood in the pulmonary artery.
  • the catheter type sensor 150 is introduced into the pulmonary artery by the right heart catheterization in the manner described above.
  • the connector 15 of the sensor 150 is connected to the connector 73 of the apparatus body 100.
  • the thermistor 2 is connected through the lead 24 to a constant-voltage circuit 112 for driving the thermistor 2 and to a blood temperature detecting circuit 113 for detecting the temperature of the blood.
  • the pulmonary artery blood temperature from the thermistor 2 is detected by the blood temperature detecting circuit 113 as a voltage signal Eb.
  • the thermistor 1 is connected through the lead 22 to a thermistor temperature detecting circuit 115 and to a constant-current circuit 111.
  • the constant-current circuit 111 supplies a predetermined amount of current Ic to the thermistor 1 to heat it.
  • the temperature signal detected by the thermistor 1 is sent to the thermistor temperature detecting circuit 115 where it is detected as a voltage Et.
  • the thermistor 12a incorporated in the injectate temperature probe 12 is driven by a constant-voltage circuit 101, and the changes in the temperature detected by the thermistor 12a are detected by a injectate temperature detecting circuit 102 as a voltage Ei.
  • the local CPU 105 receives these three voltages Ei, Et, and Eb, and converts them into the injectate temperature Ti, the resistance Rt of the thermistor 1, the temperature Tt of the thermistor 1, and the blood temperature Tb.
  • the local CPU 105 inputs Ei, Et and Eb to a 14-bit A/D converter 104 on the time-sharing basis by driving an analog switch 103 having the multiplex function, and then stores the resultant digital values sequentially in a RAM 107.
  • the digital values are converted into temperature data using the voltage-temperature conversion table stored in a ROM 106.
  • the local CPU 105 sends the data, such as Ti, Rt, Tt, and Tb, to the measuring/recording circuit 130 through an optical communication line.
  • the communication control (which may be performed by the known polling/selecting method) is performed by the local CPU 105 and the main CPU 133.
  • the use of the 14-bit A/D converter 104 having a relatively high resolution enables the measurement of a high cardiac output area which will be described later.
  • the measuring/recording circuit 130 receives by using the above-described simple communication control procedure the injectate temperature Ti, the resistance Rt of the thermistor 1, the temperature Tt of the thermistor 1, the blood temperature Tb and so on and stores the data ordered in time in a RAM 132.
  • the CPU 133 then operates the initial cardiac output COo, the blood flow velocity Vo (or Vx), the continuous cardiac output COx from the data that it received.
  • An RTC (real time clock circuit) 147 counts the real time. Also, it monitors the time, e.g., 30 seconds in which the display of Ti is to be changed to that of Tb in the LED display 69.
  • Fig. 10A shows the structure of the data stored in the RAM 132.
  • the capacity of the RAM 132 is divided into an area (132a) in which data such as Tb obtained by A/D converting the data each 40 ms over 30 minutes is stored, an area (132b) in which the data such as the continuous cardiac output COx which is obtained over 30 minutes at an arbitrary time is stored, and an area (132c) in which average values of data such as continuous cardiac output COx obtained over 12 hours in 1.5 minutes are stored.
  • Fig. 10B shows how three address counters 160, 161 and 162 for storing data in the RAM 132 correspond to the three areas (132a, 132b, 132c).
  • the data storage address counter (an SC pointer) 160 is used to point the address at which the data from the measuring circuit 120 is stored in the RAM 132.
  • the data read-out address counter (an RC pointer) 161 is used to point the address of the data to be read out from the RAM 132 when the initial cardiac output COo is calculated or the address at which the calculated value is stored in the RAM.
  • the data print address counter (a PC pointer) 162 points the address of the data to be output to the plotter 50.
  • This embodiment employs three pointers, because the data storage, the data read-out and the data output are performed independently of each other.
  • Fig. 11 is a flowchart of the subroutine executed by the main CPU 133 when it receives the data from the local CPU 105 and stores them in the RAM 132.
  • the SC pointer is used when data is stored in the RAM 132.
  • Figs. 13A and 13B are flowcharts of the control routine which is executed by the CPU 133 when it calculates the initial cardiac output COo.
  • the control routine shown in Figs. 13A and 13B includes the automatic measurement starting function.
  • step S40 it is determined whether or not the measuring apparatus is in a ready state. It is determined that the apparatus is ready when the blood temperature Tb is detected under the stable condition with no failure in the hardware of the apparatus. In order to determine that Tb is in a stable state, variance of Tb in a fixed period of time is operated, and as to whether the variance is equal to or smaller than a predetermined value is then determined. Once it is detected that the apparatus is in a ready state, the START indicator 72 lights up, as stated above. It is then determined in step S41 whether or not the START indicator 72 has been pressed.
  • step S50 the time t is read by the real time clock RTC 147, and the pointer value corresponding to the time t read is then set in the RC pointer 161 in step S51. Thereafter, in step S52, the injectate temperature Ti is fetched from the RAM 132. In step S53, one Tb designated by the RC pointer 161 is read out from the RAM 132. In step S54, the base line temperature Tbo is detected from the data stored in the memory before the time t. Tbo may be the average temperature of the small variance which is used in the determination of the ready state of the apparatus.
  • step S56 ⁇ Tb (integration) is calculated. ⁇ Tb corresponds to ⁇ 0 ⁇ ⁇ Tb dt in the Stewart/Hamilton Equation.
  • step S57 it is determined in step S57 whether or not the blood temperature has dropped within a fixed period of time. If it is determined in step S57 that the temperature drop ⁇ Tb is smaller than a predetermined threshold THo, i.e., if it is determined that the indicator does not reach the thermistor 2 yet, the counter ERTIM is incremented by one in step S58.
  • step S60 If ⁇ Tb remains equal to or smaller than THo until the ERTIM overflows, it is determined that the apparatus is in an abnormal state, and an error display is conducted in step S60. In this erroneous state, the display 68 displays "Er", as well as an error code number.
  • step S57 If the apparatus is operating normally and if the indicator is injected, it is determined in step S57 that ⁇ Tb > THo within a fixed period of time.
  • the integration ⁇ Tb is performed in step S56.
  • the results of the integration performed in step S56 is 0.
  • Noise may be generated. However, variations caused by the noise have both positive and negative values, so the results of the integration is also 0.
  • step S57 Once it is detected in step S57 that ⁇ Tb > THo, the process goes to step S61 where the peak of the dilution curve is detected.
  • Tbmax used in step S61 represents the maximum temperature drop from Tbo which occurs while the temperature is lowering. Tbmax is initially set to 0. Once the temperature drops (until the peak is detected), it is determined in step S61 that ⁇ Tb > ⁇ Tbmax, so ⁇ Tbmax is updated in step S62.
  • step S63 temperature ⁇ Tbc (used in step S68) which serves as the standard point at which the integration is suspended is updated. Theoretically, the longer the period during which the integration is performed, the higher the accuracy.
  • the period of the integration may be hence any value including an infinity.
  • the long period of the integration does not ensure high measurement efficiency.
  • the results of the integration is easily affected by noise. So, ⁇ Tbc has to be the lower limit value which ensures both the sufficiently high accuracy and the sufficiently high measurement efficiency (the period of the integration is shortened). Since the magnitude of the peak temperature ⁇ Tbmax affects the ⁇ Tbc, ⁇ Tbc is updated in step S63 each time ⁇ Tbmax is updated. In step S64, the RC pointer is incremented so that it points new temperature data. Thereafter, the process returns to step S53 to repeat the above-described processing. Thus, the integration is continued until the peak of the dilution curve is detected.
  • step S61 the answer of the determination made in step S61 becomes negative, and the process goes to step S66 where it is determined whether or not ⁇ Tbmax - ⁇ Tb > THb, where THb is a predetermined threshold.
  • THb is a predetermined threshold.
  • the peak flag indicates that the peak has been detected at least once after the measurement had been started.
  • step S68 it is determined in step S68 whether or not the blood temperature has gone up (the dilution curve drops ) and reached a critical temperature ⁇ Tbc at which integration is to be stopped.
  • step S64 If the temperature rise ⁇ Tb does not yet reach ⁇ Tbc, the process goes to step S64, and then returns to step S53 to continue the integration.
  • step S69 the peak flag is checked. Since the peak flag has been set, the processing proceeds to step S70 and the initial cardiac output COo is operated. This clarifies the significance of the peak flag: it may be possible that it is determined in step S68 that ⁇ Tb ⁇ ⁇ Tbc before no peak has been detected. So, only when the peak represented by ⁇ Tbmax - ⁇ Tb > THb has been detected, the peak flag is set, preventing erroneous stoppage of the integration, which would occur when the peak flag is not set. If THo and THb are the same threshold, the processings related to the setting of the peak flag (in steps S66, S67, S69 and S70) are eliminated.
  • ⁇ Tbc is preferably set to a value which is substantially the same as ⁇ Tbo.
  • the processings in step S70 to S75 will be described later after automatic starting of the measurement has been described.
  • the operation of the initial cardiac output COo is thus performed when measurement is manually started.
  • Non-pressing of the START switch 72 is detected either when the operator intends to automatically start the measurement or when the operator does not yet press the START switch 72. Furthermore, in this embodiment, it is determined that the operator intends to start the measurement automatically when there exists predetermined changes in the temperature Tb. In other words, while the START switch 72 is not being pressed, both the changes in the temperature Tb and the pressing of the switch 72 have to be monitored. This monitoring of the temperature is performed in step S43 and the subsequent steps. Pressing of the switch 72 is detected as an interrupt in the loop consisting of steps S42 to S47. Once the interrupt occurs in the above-described loop, the processing forcibly goes to step S50.
  • Tb is read out of the RAM 132 in accordance with the RC pointer 161 in step S42.
  • a change in Tb is represented by a moving average value (of 16 samples) of Tb
  • a required number of samples are fetched from the memory 132 in the loop consisting of steps S42, S43, and S44.
  • the moving average value is one sample data. Once the required number of samples have been obtained, a total number of samples required to obtain the average value are obtained each time one sample data is read out from the memory 132.
  • the moving average value, Tb(n) is obtained.
  • step S46 the difference between this moving average value and the preceding moving average value Tb(n-1) is obtained. If the difference is equal to or larger than a predetermined threshold THd, it is determined that the temperature of the blood has changed due to the injectate, and the time t at which this change takes place is then calculated in step S49. Calculation of the time t is necessary, because the detection of the change in the temperature is delayed from the time at which change in the temperature actually occurs. The subsequent processings are the same as those executed when pressing of the START switch 72 is detected.
  • step S47 If it is determined in step S47 that the change in the temperature is smaller than the threshold THd, the present average value Tb (n) is moved into the preceding average value Tb(n-1) storage area in step S48.
  • the average value Tb(l) may be replaced by the real time value Tb obtained 2 seconds before.
  • Integration calculation is thus performed when it is manually or automatically started.
  • step S71 The processing executed in step S71 will be described below.
  • Stewart/Hamilton Equation is expressed as follows: where CO: the cardiac output, Si: the specific gravity of the injectate, Ci : the specific heat of the injectate, Vi: the injectate volume, Ti: the injectate temperature, Tb: the temperature of the blood, Sb: the specific gravity of the blood, Cb: the specific heat of the blood.
  • the aforementioned equation is also expressed as follows: where In this constant A, whereas Si, Sb, Cb and Ci are fixed values, the volume of injectate Vi may vary because part of the indicator remains within the catheter when it is injected into the blood vessel after the temperature thereof has been set to a predetermined value. In other words, Vi is a nominal value.
  • the correction constant A' is obtained by referring to a table which is created through the experiments using the catheter size, the volume Vi of indicator and so on.
  • the correction constant A' is (Fig. 12) stored in the ROM 131 in a tabulated form.
  • the CPU 133 reads the values set in the switches 59 and 60 through the I/O port 134, and converts these values and the temperature Ti of the indicator into the address data with which it addresses the ROM 131.
  • the correction constant data contained in the table is obtained in the actual measurements which were conducted using the catheter having various sizes and various volumes of indicator. If the size of the actually employed catheter and the injectate volume correspond to no value contained in the table, a correction constant A' is obtained by the linear interpolation using the values existing in the table which are close to the above-described values.
  • step S68 After the integration, ⁇ Tb, has been completed in step S68, the correction constant A' is read out from the table (Fig. 12) stored in the ROM 131 in step S71 in the manner described above using the outer diameter Fr of the catheter and the injectate volume ml, which are input by means of the switches 59 and 60.
  • step S72 the initial cardiac output COo is calculated on the basis of the Stewart/Hamilton Equation described above.
  • step S74 the parameter S, which is required to calculate the continuous cardiac output Cox, is calculated.
  • step S75 the thus-obtained values are output to the plotter in the form shown in, for example, Figs. 4 and 5.
  • the quantity of heat which is lost from the thermistor 1 in accordance with the blood flow is expressed as follows: K ⁇ V ⁇ (Tt - Tb) where Tb is the temperature of the blood, Tt is the temperature of the heated thermistor, and K is the constant of proportion.
  • the temperature of the thermistor 1 is kept at a value at which the quantity of heat generated by the heated thermistor is equal to that lost from the thermistor. This temperature is called heat balanced temperature.
  • the blood flow velocity V is obtained from the data Rt and Tt obtained from the thermistor 1 and the blood temperature Tb obtained from the thermistor 2. Since the thermistor 1 is driven by the constant-current circuit 111, the potential Eo between the two ends of the lead for the thermistor 1 may be detected in place of the resistance of the thermistor 1. This detection is described in detail in the specification of Japanese Patent Laid-Open No. 61-125329. In this embodiment, the constant-current value Ic is obtained by detecting the current in the constant-current circuit 111. However, it may be stored within the ROM 131 as the constant term, like the constant of proportion K.
  • the cross-sectional area s of the blood vessel is obtained from the initial cardiac output COo and the initial blood flow velocity V by using Equation (4), and the obtained s is held within the measuring/recording circuit 130 as a parameter.
  • Fig. 14A shows in detail the processing executed in step S72 in Fig. 13 in which the parameter s is calculated.
  • step S112 an instruction of heating the thermistor 1 is given to the local CPU 105 through the optical communication path in step S110 shown in Fig. 14A.
  • step S112 the thermistor 1 being heat balanced is awaited. Soon, Tt, Rt, and Tb arrive from the local CPU, the arrived data being stored in sequence in the RAM 132 by the procedure shown in Fig. 11.
  • step S113 the data stored in the RAM 132 is accessed by means of the RC pointer 161 in accordance with the time t.
  • step S114 the initial blood flow velocity Vo is calculated on the basis of Equation (3), and the parameter s is then obtained in step S115 on the basis of Equation (4) utilizing the relationship between the initial cardiac output COo and the blood flow velocity Vo.
  • step S80 it is determined in step S80 whether or not the measuring apparatus 100 is in the continuous mode. This is achieved by pressing the CONTINUOUS switch 64. If the measuring apparatus 100 is in the continuous mode, an instruction of heating the thermistor 1 is given to the local CPU 105 through the optical communication path in step S81. In step S82, the thermistor 1 being heat balanced is awaited. Soon, Tt, Rt and Tb arrive from the local CPU, the arrived data being stored in sequence within the RAM 132 by the procedure shown in Fig. 11. In consequence, the data stored in the RAM 132 is accessed by means of the RC pointer 161 in accordance with the time t. In step S84, the blood flow velocity Vx is calculated on the basis of Equation (3).
  • step S86 It is determined in step S86 whether or not the measuring apparatus 100 is still in the continuous mode. This is done because the parameter s representing the cross-sectional area of the blood vessel generally changes with time, making it impossible for an accurate cardiac output to be obtained using the parameter s held. Hence, the initial cardiac output CO is measured by the thermal dilution method at adequate intervals so that it can be used in a subsequent continuous measurement of COx.
  • step S88 the average values of Vx and COx in 1.5 minutes are operated, which will be used in the reproduction of data obtained over 12 hours (Fig. 8).
  • the values obtained in step S88 are stored in the area 132c in the RAM 132.
  • step S90 the RC pointer is incremented by one for the subsequent operation of COx.
  • COx can be continuously operated each time Tt, Rt, and Tb arrive from the local CPU, which means that COx can be measured by measuring the blood flow velocity Vx.
  • the measuring apparatus 100 has the continuous recording function (which is performed by pressing the switch 56) in which the measured value is output to the plotter 50 while it is being continuously obtained, the reproduction function (performed by pressing the switch 55) in which the measured values obtained over 30 minutes are output to the plotter 50, and the record output function (performed by pressing the switch 54) in which the measured values obtained over 12 hours (the average values in each 3 minutes) are output to the plotter 50, in addition to the thermal dilution curve recording function shown in Fig. 4 and the thermal dilution value recording function shown in Fig. 5.
  • the recording paper is fed at a speed of 10 m/min, as shown in Fig. 6, or at a speed of 20 ms/hour, as shown in Fig. 7.
  • Fig. 8 shows an example of the record.
  • the above-described recordings are performed in the continuous mode (while the CONTINUOUS indicator 64 is lighting up). This means that the reception of data from the local CPU 105 and the operation/storage of COx have to be performed parallel to the output of data to the plotter 50.
  • the PC pointer is used when the data in the RAM 132 is accessed and output to the plotter 50, the SC pointer 160 is used to fetch the data, and the RC pointer 160 is used for operation/storage.
  • the injectate temperature is determined by the temperature of the container. In consequence, in a case where the temperature of the container is a known value (for example, zero), that temperature may substitute for that of the indicator.
  • the injectate temperature detecting circuit 102 detects that the current that flows in the thermistor 12a connected to the constant-voltage circuit 101 is zero, and sends Ei corresponding to the zero current to the local CPU 105.
  • the local CPU 105 sends a corresponding signal to the main CPU 133.
  • the CPU 105 converts Ei corresponding to the zero current into an impossible temperature value Ti, and sends the resultant signal to the main CPU 133.
  • the CPU 133 detects the non-connection of the temperature probe 12.
  • Fig. 15 is a flowchart of this control procedure.
  • step S100 it is determined in step S100 whether or not Ti received from the local CPU 105 represents non-connection of the probe 12. If Ti represents connection, Ti stored in the RAM 132 is fetched in the CPU 133 in step S101. If Ti represents non-connection, the data set by means of the switch 75 is fetched as Ti in step S102.
  • the initial cardiac output COo is actually obtained by the thermal dilution method, and the parameter s is then obtained from the relation between the COo and the initial blood flow velocity Vo. Thereafter, the cardiac output COx is continuously obtained by measuring the blood flow velocity Vx at an arbitrary time.
  • COx ⁇ Vx and changes in Vx reflects relative changes in COx.
  • recording of changes in Vx means recording of relative changes in COx.
  • a measuring system was formed by connecting the catheter 4 shown in Fig. 2A to the measuring apparatus shown in Figs. 9A and 9B. Two experiments were conducted using this measuring system. In one experiment, the measuring system was applied to the circulatory model circuit. The other was the experiment on the dog which was the 15 Kg adult mongrel under an anesthetic. The model circuit was constructed by a constant-temperature tank, a pump and so on. In the latter experiment on the animal, the catheter 4 which was introduced from the right internal jugular vein was advanced into the pulmonary artery. Comparison example was obtained using the electromagnetic blood flowmeter.
  • Fig. 19 shows the results of the measurement obtained in the circulatory model circuit. In the graph shown in Fig.
  • the present invention can be applied to the dilution methods other than the thermal dilution method, e.g., the dye dilution method or the electrolyte dilution method.
  • the dye dilution method initial cardiac output CO is obtained by measuring the change in the illuminance in, for example, an earlobe which occurs in accordance with the amount of dye in the blood.
  • the electrolyte dilution method the initial cardiac output CO is obtained by measuring the change in the resistance in the blood by means of two electrodes provided in the catheter.
  • the function of inputting the data (e.g., Fr or ml) upon which the correction constant A' is based, which is described in Item (1) can be applied to any type of indicator dilution method which employs a catheter.
  • the automatic measurement starting function described in Item (2) can be applied to the measurement of a change in the illuminance or the resistance.
  • the continuous cardiac output measuring function described in Item (4) can be applied to the calculation of COx from the parameter s obtained on the basis of the initial cardiac output COo obtained by any indicator dilution method and from the blood flow velocity Vx obtained at an arbitrary time.
  • Connection/non-connection of the temperature probe 12 may also be detected by the following mechanism: a protrusion is provided at the portion of the measuring apparatus body to which the connector 16 of the probe is connected in such a manner that it is urged. When the connector 16 is connected to this protrusion, the protrusion retreats, by means of which the end of the protrusion supplies, for example, an earth signal, to the measuring circuit 120. The measuring circuit 120 determines connection/non-connection of the probe 12 by the presence and absence of the earth signal. The protrusion is electrically isolated from the measuring circuit 120 except for its end, so as to allow the measuring circuit 120 to be electrically isolated.
  • the blood flow velocity is measured by the thermistor 1 which detects the voltage representing the heat balance, i.e., change in the resistance of the thermistor, which is obtained when a constant current flows therein.
  • the thermistor 1 which detects the voltage representing the heat balance, i.e., change in the resistance of the thermistor, which is obtained when a constant current flows therein.
  • it may also be measured by measuring the current required to maintain the difference in the temperature of the blood and that of the thermistor constant. More specifically, the temperature of the thermistor is maintained at 45 °C which is the upper limit of the temperatures which do not affect the human body, and the current required to maintain the temperature of the thermistor at that value is measured.
  • Blood flow velocity sensors other than the thermistor may also be used.

Claims (14)

  1. Herzleistungsmeßgerät enthaltend:
       Herzleistungsmeßeinrichtung (Schritte S40 bis S72 in den Fig. 13A und 13B) zur Durchführung der Messung einer Herzleistung auf der Basis eines Verdünnungsverfahrens mindestens einmal, um eine anfängliche Herzleistung zu erhalten;
       Blutdatendetektionseinrichtung (1, 2; Fig. 2A) zur Messung einer Blutflußgeschwindigkeit in der Nähe des Teils eines Blutgefäßes, bei dem die Herzleistung durch die Herzleistungsmeßeinrichtung gemessen ist;
       Funktionserstellungseinrichtung (Schritte S110-115 in Fig. 14A) zum Erstellen einer Funktion, die die Beziehung zwischen der Herzleistung, die auf der Basis des Verdünnungsverfahrens erhaltenen wird, und einer Blutflußgeschwindigkeit, die erhalten wird, wenn die Herzleistung gemessen wird, darstellt;
       Herzleistungserstellungseinrichtung (Schritte S83-90 in Fig. 14B) zur kontinuierlichen Erstellung einer Herzleistung zu individuellen Zeitpunkten auf der Basis der Funktion und der Blutflußgeschwindigkeiten, die zu den Zeitpunkten durch die Blutdatendetektionseinrichtung (1, 2) erhalten sind;
       Injektionseinrichtung (3; Fig. 2A) zur Injektion eines Indikators in das Blutgefäß, wobei die Blutdatendetektionseinrichtung (1, 2) zur Ausgabe der Daten des Bluts, das durch den injizierten Indikator verdünnt ist, dient und
       Integrationseinrichtung (Schritt S56 in Fig. 13B) zur Berechnung einer zeitlichen Integration der Blutdaten;
       gekennzeichnet durch
       Speichereinrichtung (132 in den Fig. 10A und 10B) zur Speicherung der Herzleistungen, die zu individuellen Zeitpunkten in der Reihenfolge, in der sie erzeugt sind, erhalten sind;
       Aufzeichnungseinrichtung (90 von Fig. 9B) zur visuellen und rückwirkenden Aufzeichnung von gespeicherten Herzleistungen,
       Eingabeeinrichtungen (59, 60) zur manuellen Eingabe einer Vielzahl von Datentypen bezüglich der Wärmekapazität des durch die Injektionseinrichtung injizierten Indikators unabhängig voneinander; und
       Herzleistungserstellungseinrichtung (Schritt S72 in Fig. 13B) zur Erstellung einer Herzleistung aus dem Integralwert und den Daten bezüglich der Wärmekapazität, die entsprechend dem thermischen Verdünnungsverfahren eingegeben ist.
  2. Herzleistungsmeßgerät gemäß Anspruch 1, wobei die Blutdatendetektionseinrichtung (1, 2) einen Temperatursensor einschließt, und wobei die Blutdaten Daten bezüglich der Bluttemperatur darstellen.
  3. Herzleistungsmeßgerät gemäß Anspruch 1, wobei die Injektionseinrichtung (3) einen Katheter (4) einschließt, und wobei die Daten bezüglich der Wärmekapazität das Volumen des injizierten Indikators darstellen.
  4. Herzleistungsmeßgerät gemäß Anspruch 1, wobei die Injektionseinrichtung (3) einen Katheter (4) einschließt, und wobei die Daten bezüglich der Wärmekapazität den Außendurchmesser des Katheters (4) darstellen.
  5. Herzleistungsmeßgerät gemäß Anspruch 1, wobei die Injektionseinrichtung (3) einen Katheter (4) einschließt, und wobei die Daten bezüglich der Wärmekapazität die Temperatur des Indikators darstellen.
  6. Herzleistungsmeßgerät gemäß Anspruch 1, wobei die Eingabeeinrichtungen (59, 60) numerische Eingabetasten einschließen.
  7. Herzleistungsmeßgerät gemäß Anspruch 2, wobei die Herzleistungserstellungseinrichtung eine Korrekturtabelle einschließt, die die Daten bezüglich der Wärmekapazität speichert, wobei die Erstellungseinrichtung die Herzleistung mit Hilfe des Ausgabewerts der Korrekturtabelle erstellt.
  8. Herzleistungsmeßgerät gemäß Anspruch 1, wobei das Verdünnungsverfahren das thermische Verdünnungsverfahren ist, wobei die Blutdatendetektionseinrichtung einen Katheter (4) mit einer Öffnung, durch die der Indikator in das Blut injiziert ist, einen ersten Thermistor (1) zur Temperaturmessung des durch den Indikator verdünnten Blutes an der stromabwärts gelegenen Seite des Blutgefäßes, eine Integrationseinrichtung zur Integration der durch den ersten Thermistor (1) detektierten Bluttemperaturdaten und einen zweiten selbstheizenden Thermistortypen (12a), der in der Nähe des ersten Thermistors (1) des Katheters (4) angebracht ist, einschließt.
  9. Herzleistungsmeßgerät gemäß Anspruch 8, gekennzeichnet durch den Einschluß eines ersten Mikroprozessors (105) zur Datenerfassung, eines zweiten Mikroprozessors (133) zur Datenverarbeitung und einer Übertragungseinrichtung (108) zum Austausch der Daten zwischen den beiden Mikroprozessoren (105, 133), wobei der erste Mikroprozessor (105) die durch den ersten Thermistor (1) detektierten Bluttemperaturdaten und die durch den zweiten Thermistor (12a) detektierten Temperaturdaten im Wärmegleichgewicht erfaßt und sie mit Hilfe der Übertragungseinrichtung (108) an den zweiten Mikroprozessor (133) sendet, und wobei der zweite Mikroprozessor (133) die erfaßten Daten verarbeitet und dabei die anfängliche Herzleistung und die Funktion erstellt.
  10. Herzleistungsmeßgerät gemäß Anspruch 1, wobei die Herzleistungserstellungseinrichtung eine Einrichtung zur Komprimierung der Herzleistungen, die innerhalb einer vorbestimmten Zeitdauer erstellt sind, und einen Speicher zur Speicherung der komprimierten Herzleistungen einschließt, und wobei die Aufzeichnungseinrichtung in der Lage ist, die komprimierten Herzleistungen aufzuzeichnen.
  11. Herzleistungsmeßgerät gemäß Anspruch 1, wobei die Herzleistungsmeßeinrichtung enthält:
       Dateneinstelleinrichtung (75 in Fig. 1C) zur manuellen Einstellung von Daten bezüglich eines Indikators, der noch nicht in das Blutgefäß injiziert ist;
       Indikatormeßeinrichtung (12 in Fig. 2A) zur Messung von Daten bezüglich des Indikators, der noch nicht in das Blutgefäß injiziert ist, wobei die Blutdatendetektionseinrichtung (1, 2) Daten bezüglich des Blutes detektiert, das durch den in das Blutgefäß injizierten Indikator verdünnt ist, und wobei die Integrationseinrichtung (Schritt S56) die zu jedem Zeitpunkt erhaltenen Blutdaten integriert; und
       Auswahleinrichtung (Schritte 100-102 in Fig. 15) zur Auswahl entweder der durch die Dateneinstelleinrichtung (75) eingestellten Daten oder der durch die Indikatormeßeinrichtung (12) erhaltenen Daten;
       wobei die Herzleistungserstellungseinrichtung eine Herzleistung aus dem von der Integrationseinrichtung erhaltenen Integralwert und dem durch die Auswahleinrichtung ausgewählten Wert erstellt.
  12. Herzleistungsmeßgerät gemäß Anspruch 11, wobei die Indikatormeßeinrichtung (12) eine Meßsonde (12, 16 in Fig. 2A) einschließt, die an das Herzleistungsmeßgerät angeschlossen ist, wobei das Herzleistungsmeßgerät weiterhin eine Nicht-Anschlußdetektionseinrichtung (Schritt S100 in Fig. 15) zur Detektion des Nicht-Anschlusses der Meßsonde an das Herzleistungsmeßgerät einschließt, und wobei die Auswahleinrichtung die von den Eingabeeinrichtungen (59, 60) eingegebenen Daten als die Indikatordaten auswählt (Schritt 102 in Fig. 15), nur wenn die Nicht-Anschlußdetektionseinrichtung einen Nicht-Anschluß detektiert.
  13. Herzleistungsmeßgerät gemäß Anspruch 11, wobei die Indikatordaten bezüglich des Indikators die Temperatur des Indikators darstellen.
  14. Herzleistungsmeßgerät gemäß Anspruch 11, wobei die Dateneinstelleinrichtung numerische Eingabetasten (75 in Fig. 1C) einschließt.
EP88902239A 1987-03-05 1988-03-04 Messgerät zur messung des herzflusses Expired - Lifetime EP0374248B1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP93119022A EP0596539B1 (de) 1987-03-05 1988-03-04 Vorrichtung zur Messung des Herzzeitvolumens
EP93119023A EP0599314B1 (de) 1987-03-05 1988-03-04 Vorrichtung zur kontinuierlichen Messung der relativen Änderung des Herzzeitvolumens

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
JP62048826A JPS63216539A (ja) 1987-03-05 1987-03-05 心拍出量の相対的変化の連続測定装置
JP62048821A JPS63216540A (ja) 1987-03-05 1987-03-05 心拍出量の測定装置
JP4882287 1987-03-05
JP48824/87 1987-03-05
JP48822/87 1987-03-05
JP62048825A JPS63216538A (ja) 1987-03-05 1987-03-05 心拍出量の連続測定記録装置
JP48823/87 1987-03-05
JP48826/87 1987-03-05
JP62048823A JPS63216536A (ja) 1987-03-05 1987-03-05 心拍出量の測定装置
JP48821/87 1987-03-05
JP48825/87 1987-03-05
JP62048824A JPS63216537A (ja) 1987-03-05 1987-03-05 心拍出量の測定装置
PCT/JP1988/000239 WO1988006426A1 (en) 1987-03-05 1988-03-04 Apparatus for measuring cardiac output

Related Child Applications (4)

Application Number Title Priority Date Filing Date
EP93119022A Division-Into EP0596539B1 (de) 1987-03-05 1988-03-04 Vorrichtung zur Messung des Herzzeitvolumens
EP93119023A Division-Into EP0599314B1 (de) 1987-03-05 1988-03-04 Vorrichtung zur kontinuierlichen Messung der relativen Änderung des Herzzeitvolumens
EP93119022.7 Division-Into 1993-11-25
EP93119023.5 Division-Into 1993-11-25

Publications (3)

Publication Number Publication Date
EP0374248A1 EP0374248A1 (de) 1990-06-27
EP0374248A4 EP0374248A4 (en) 1991-05-15
EP0374248B1 true EP0374248B1 (de) 1995-05-17

Family

ID=27550334

Family Applications (3)

Application Number Title Priority Date Filing Date
EP93119023A Expired - Lifetime EP0599314B1 (de) 1987-03-05 1988-03-04 Vorrichtung zur kontinuierlichen Messung der relativen Änderung des Herzzeitvolumens
EP93119022A Expired - Lifetime EP0596539B1 (de) 1987-03-05 1988-03-04 Vorrichtung zur Messung des Herzzeitvolumens
EP88902239A Expired - Lifetime EP0374248B1 (de) 1987-03-05 1988-03-04 Messgerät zur messung des herzflusses

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP93119023A Expired - Lifetime EP0599314B1 (de) 1987-03-05 1988-03-04 Vorrichtung zur kontinuierlichen Messung der relativen Änderung des Herzzeitvolumens
EP93119022A Expired - Lifetime EP0596539B1 (de) 1987-03-05 1988-03-04 Vorrichtung zur Messung des Herzzeitvolumens

Country Status (4)

Country Link
US (1) US5046505A (de)
EP (3) EP0599314B1 (de)
DE (3) DE3856390T2 (de)
WO (1) WO1988006426A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5720293A (en) * 1991-01-29 1998-02-24 Baxter International Inc. Diagnostic catheter with memory
US6387052B1 (en) * 1991-01-29 2002-05-14 Edwards Lifesciences Corporation Thermodilution catheter having a safe, flexible heating element
US5217019A (en) * 1991-12-27 1993-06-08 Abbott Laboratories Apparatus and method for continuously monitoring cardiac output
US5305760A (en) * 1992-02-07 1994-04-26 Interflo Medical Inc. Method for rejecting electrical interference from physiological measurements
US5390679A (en) * 1993-06-03 1995-02-21 Eli Lilly And Company Continuous cardiac output derived from the arterial pressure waveform using pattern recognition
EP0640978A3 (de) * 1993-08-31 1998-10-07 Ohmeda Inc. Nicht-invasive Abtualisierungsanordnung für Software
US5425375A (en) * 1993-09-09 1995-06-20 Cardiac Pathways Corporation Reusable medical device with usage memory, system using same
GB9503787D0 (en) * 1995-02-24 1995-04-12 Monitoring Tech Ltd A method of and apparatus for analysing a signal
US5620002A (en) * 1995-12-22 1997-04-15 Abbott Critical Care Systems Method for correcting thermal drift in cardiac output determination
US5928155A (en) * 1997-01-24 1999-07-27 Cardiox Corporation Cardiac output measurement with metabolizable analyte containing fluid
US6113548A (en) * 1997-02-11 2000-09-05 Deboisblanc; Bennet P. Method and apparatus for estimation of beat-to-beat pulmonary wedge pressure
US6299583B1 (en) 1998-03-17 2001-10-09 Cardiox Corporation Monitoring total circulating blood volume and cardiac output
US6155984A (en) * 1999-04-15 2000-12-05 Transonic Systems, Inc. Method and apparatus for measuring cardiac output through an arterial cannula
US6551250B2 (en) 2001-03-29 2003-04-22 Hassan Khalil Transit time thermodilution guidewire system for measuring coronary flow velocity
US20060064059A1 (en) * 2004-09-21 2006-03-23 Mark Gelfand Treatment of infarct expansion by partially occluding vena cava
US7998082B2 (en) 2007-09-07 2011-08-16 Pronk Technologies, Inc. Thermo-dilution cardiac output measurement simulator
US9320642B1 (en) * 2012-06-04 2016-04-26 The Surgical Company International B.V. Method of and system for selecting patient temperature regulation tools
JP7177078B2 (ja) * 2017-03-21 2022-11-22 アビオメド インコーポレイテッド 埋め込み式サーミスタを有するカテーテルマウント式心臓内血液ポンプにより心臓支持を持続しながら自己心拍出量を決定するためのシステムおよび方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51185A (en) * 1974-05-24 1976-01-05 Contraves Ag Saamo dairyuushonhonyori shinzo jikan yoryoosadamerutameno chokusetsuhyojisochi
EP0182363A2 (de) * 1984-11-21 1986-05-28 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Vorrichtung zur Messung des Herzzeitvolumens

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3438253A (en) * 1966-11-15 1969-04-15 Frederick W Kuether Thermal device for measuring direction and velocity of fluid flow
US3595079A (en) * 1967-11-13 1971-07-27 Univ Northwestern Fluid flow velocity measuring apparatus
US3651318A (en) * 1970-01-26 1972-03-21 Jan A Czekajewski Cardiac output computer
US3678922A (en) * 1971-01-14 1972-07-25 Univ Temple Dilution method and apparatus for measurement of fluid flow rate
US3789831A (en) * 1972-02-11 1974-02-05 D Kopaniky Thermoelectric probe apparatus for tissue fluid flow measurement
US3820530A (en) * 1973-02-16 1974-06-28 Gifford Instr Labor Inc Cardiac output measuring method and apparatus
JPS5110690A (de) * 1974-07-15 1976-01-28 Daiya Med Syst
FR2291731A1 (fr) * 1974-11-20 1976-06-18 Obermajer Wladimir Procede et dispositif de mesure de la capacite cardiaque
US3995623A (en) * 1974-12-23 1976-12-07 American Hospital Supply Corporation Multipurpose flow-directed catheter
US4015593A (en) * 1975-03-24 1977-04-05 Elings Virgil B Apparatus and method for measuring cardiac output
US3987788A (en) * 1975-07-09 1976-10-26 American Hospital Supply Corporation System for computing cardiac flow rates from thermodilution measurements
JPS5455144A (en) * 1977-10-12 1979-05-02 Mitsui Constr Method of and device for processing medical inspection data
GB2032623A (en) * 1978-04-10 1980-05-08 Hewlett Packard Co Derivation of Steady Values of Blood Pressures
US4240441A (en) * 1978-10-10 1980-12-23 The United States Of America As Represented By The Secretary Of The Navy Carotid thermodilution catheter
US4230126A (en) * 1978-11-20 1980-10-28 Elings Virgil B Apparatus and method for measuring extravascular lung water
JPS55138166A (en) * 1979-04-13 1980-10-28 Tadashi Akanuma Measuring computer for renal blood flow
US4380237A (en) * 1979-12-03 1983-04-19 Massachusetts General Hospital Apparatus for making cardiac output conductivity measurements
JPS57182656A (en) * 1981-05-06 1982-11-10 Nissin Electric Co Ltd Trigger device
US4407298A (en) * 1981-07-16 1983-10-04 Critikon Inc. Connector for thermodilution catheter
US4572206A (en) * 1982-04-21 1986-02-25 Purdue Research Foundation Method and apparatus for measuring cardiac output
US4502488A (en) * 1983-01-13 1985-03-05 Allied Corporation Injection system
US4509526A (en) * 1983-02-08 1985-04-09 Lawrence Medical Systems, Inc. Method and system for non-invasive ultrasound Doppler cardiac output measurement
US4542748A (en) * 1983-03-07 1985-09-24 American Hospital Supply Corp. Apparatus and method for measuring cardiac output
NL189547C (nl) * 1983-04-12 1993-05-17 Univ Erasmus Stelsel voor het bepalen van de stroomsterkte van het hart van een patient.
US4621646A (en) * 1983-12-15 1986-11-11 The United States Of America As Represented By The Secretary Of The Army Blood flow measuring method
US4632125A (en) * 1984-01-13 1986-12-30 American Hospital Supply Corp. Right heart ejection fraction and cardiac output catheter
US4637401A (en) * 1984-11-01 1987-01-20 Johnston G Gilbert Volumetric flow rate determination in conduits not directly accessible
JPS62207435A (ja) * 1986-03-07 1987-09-11 テルモ株式会社 心拍出量測定用カテ−テル

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51185A (en) * 1974-05-24 1976-01-05 Contraves Ag Saamo dairyuushonhonyori shinzo jikan yoryoosadamerutameno chokusetsuhyojisochi
EP0182363A2 (de) * 1984-11-21 1986-05-28 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Vorrichtung zur Messung des Herzzeitvolumens

Also Published As

Publication number Publication date
WO1988006426A1 (en) 1988-09-07
DE3856499T2 (de) 2002-07-11
EP0596539A3 (en) 1997-10-01
EP0374248A1 (de) 1990-06-27
EP0596539A2 (de) 1994-05-11
DE3856390D1 (de) 2000-02-17
US5046505A (en) 1991-09-10
EP0599314A3 (de) 1997-10-01
DE3853826D1 (de) 1995-06-22
DE3853826T2 (de) 1995-10-12
DE3856390T2 (de) 2000-07-27
EP0374248A4 (en) 1991-05-15
EP0599314A2 (de) 1994-06-01
EP0596539B1 (de) 2000-01-12
EP0599314B1 (de) 2001-10-24
DE3856499D1 (de) 2001-11-29

Similar Documents

Publication Publication Date Title
EP0374248B1 (de) Messgerät zur messung des herzflusses
US4576182A (en) Method and apparatus for measuring liquid flow
CA1327388C (en) Noninvasive continuous mean arterial blood pressure monitor
EP0368296B1 (de) Verfahren und Vorrichtung zur Messung des Herzzeitvolumens
EP0235811B1 (de) Katheter zur Messung des Herzzeitvolumens und der Geschwindigkeit der Blutströmung
US5788647A (en) Method, system and apparatus for evaluating hemodynamic parameters
US4206755A (en) Method and apparatus for the control and regulation of glycemia
EP0182363B1 (de) Vorrichtung zur Messung des Herzzeitvolumens
EP0378234B1 (de) Vorrichtung zur Messung des Herzzeitvolumens
CA2430411A1 (en) Method and device for measuring blood gas parameters
US5383468A (en) Cardiac output and right ventricular ejection fraction system
EP1655603B1 (de) Vorrichtung zur Messung des Harnzuckerspiegels
JPS63216539A (ja) 心拍出量の相対的変化の連続測定装置
JPH0467857B2 (de)
JPH0467853B2 (de)
EP0246920A2 (de) Gerät zur Ableitung des Minutenvolumens der rechten Herzkammer aus Temperaturverdünnungskurven hoher Wiedergabequalität
JPH0467854B2 (de)
JPH0467855B2 (de)
JPS63216538A (ja) 心拍出量の連続測定記録装置
EP0354958B1 (de) Gerät zum messen von daten des lebenden körpers
CN114778631B (zh) 身体指标检测装置及方法
JP2511153B2 (ja) 心拍出量測定装置
JPH0761323B2 (ja) 心拍出量測定装置

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19890905

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE DE FR GB IT NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19910327

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE DE FR GB IT NL SE

17Q First examination report despatched

Effective date: 19930708

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR IT SE

XX Miscellaneous (additional remarks)

Free format text: TEILANMELDUNGEN 93119022.7, 93119023.5.

ITF It: translation for a ep patent filed

Owner name: FUMERO BREVETTI S.N.C.

REF Corresponds to:

Ref document number: 3853826

Country of ref document: DE

Date of ref document: 19950622

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20060302

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20060308

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20060331

Year of fee payment: 19

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070305

EUG Se: european patent has lapsed
REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20071130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071002

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20060306

Year of fee payment: 19

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070402

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070304